I

ImmunoBiology Ltd

8 employees

ImmBio is developing next-generation vaccines targeting a number of serious infectious diseases, based on its proprietary technologies.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Health Care
Pharmaceutical

Date founded

1999

Funding rounds raised

Total raised

$4.8M

from 3 investors over 3 rounds

I

ImmunoBiology Ltd raised $4.8M on October 1, 2012

Investors: YFM Equity Partners

I

ImmunoBiology Ltd raised undisclosed on November 1, 2005

Investors: HYGEA VCT PLC

I

ImmunoBiology Ltd raised undisclosed on December 1, 2000

Investors: Oxford Technology Management

FAQ